Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
In our prospective, unicenter cohort study, we collected blood samples from 30 newly kidney transplanted patients, at month 1, 2, 3, and 5 for dd-cfDNA analysis, along with creatinine/eGFR and DSA monitoring, and from 32 patients who underwent an indication biopsy and whose dd-cfDNA levels were meas...
Main Authors: | Evangelos Mantios, Vassilis Filiopoulos, Pantelis Constantoulakis, George Liapis, Angeliki Vittoraki, Silvia Casas, Smaragdi Marinaki, John N Boletis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Transplant International |
Subjects: | |
Online Access: | https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11507/full |
Similar Items
-
Liver Transplantation and dd-cfDNA: A Small Solution for a Big Problem
by: Eleni Avramidou, et al.
Published: (2023-02-01) -
The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01) -
Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
by: Louise Benning, et al.
Published: (2023-11-01) -
Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01) -
Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnostics
by: Ruo Jia, et al.
Published: (2025-02-01)